|
|
| Rejuveinix (RJX) / Reven Holdings (0 Trials) |
|
| Rekambys (rilpivirine LA) / J&J (0 Trials) |
|
| Rekovelle (follitropin delta) / Ferring (14 Trials) |
|
| REL-10xx / Relmada Therapeutics (0 Trials) |
|
| relacatib (GSK-462795) / GSK (1 Trials) |
|
| Relafen (nabumetone) / GSK (0 Trials) |
|
| relamorelin (RM-131) / AbbVie (0 Trials) |
|
| relatlimab (BMS-986016) / BMS (49 Trials) |
|
| relaxin (mRNA-0184) / AstraZeneca, Moderna (0 Trials) |
|
| Relday (once-monthly formulation of risperidone) / Durect (0 Trials) |
|
| reldesemtiv (CK-2127107) / Astellas, Cytokinetics (2 Trials) |
|
| relebactam (MK-7655) / Merck (MSD) (2 Trials) |
|
| relenopride (YKP-GI) / SK Bio (0 Trials) |
|
| Relenza (zanamivir) / GSK, Vaxart (1 Trials) |
|
| Releuko (filgrastim-ayow) / Amneal (0 Trials) |
|
| Relfydess (relabotulinumtoxinA) / Galderma (0 Trials) |
|
| ReliBeta (interferon beta-1a biosimilar) / Reliance Life Sci (0 Trials) |
|
| ReliFeron (recombinant interferon α biosimilar) / Reliance Life Sci (0 Trials) |
|
| ReliGrast (filgrastim biosimilar) / Reliance Life Sci (0 Trials) |
|
| ReliPoietin (recombinant human erythropoietin biosimilar) / Reliance Life Sci (1 Trials) |
|
| Relistor (methylnaltrexone bromide) / Ono Pharmaceutical, Bausch Health (10 Trials) |
|
| Relivar (dronabinol buccal) / Sumitomo Pharma, Tetra Bio-Pharma (0 Trials) |
|
| Rellidep (egg-derived biological isolate) / United Paragon Associates (0 Trials) |
|
| reloxaliase (ALLN-177) / Allena Pharma (1 Trials) |
|
| reltecimod (AB103) / Atox Bio (2 Trials) |
|
| relutrigine (PRAX-562) / Praxis Precision Medicines (0 Trials) |
|
| Relyvrio (phenylbutyrate/taurursodiol) / Amylyx (1 Trials) |
|
| REM-001 therapy / Kintara Therap (1 Trials) |
|
| REM0043039 / ReMYND (0 Trials) |
|
| REMD-128 / REMD Bio (0 Trials) |
|
| REMD-183 / REMD Bio (0 Trials) |
|
| REMD-345 / REMD Bio (0 Trials) |
|
| REMD-352 / REMD Bio (0 Trials) |
|
| REMD-355 / REMD Bio (0 Trials) |
|
| REMD-372 / REMD Bio (0 Trials) |
|
| REMD-378 / REMD Bio (0 Trials) |
|
| REMD-380 / REMD Bio (0 Trials) |
|
| REMD-456A / REMD Bio (0 Trials) |
|
| REMD-511 / REMD Bio (0 Trials) |
|
| REMD-524 / REMD Bio (0 Trials) |
|
| REMD-532 / REMD Bio (0 Trials) |
|
| REMD-556 / REMD Bio (0 Trials) |
|
| REMD-642 / REMD Bio (0 Trials) |
|
| REMD-656 / REMD Bio (0 Trials) |
|
| REMD-813 / REMD Bio (0 Trials) |
|
| remdesivir / Generic mfg. (0 Trials) |
|
| remdesivir inhalation / Lupin (0 Trials) |
|
| remdesivir inhalation (GS-5734 inhalation) / Gilead (0 Trials) |
|
| remdesivir oral (GS-5734 oral) / Lupin (0 Trials) |
|
| Remedisc (SB-01) / Spine Biopharma (1 Trials) |
|
| Remegal (beprodon) / MarcoPolo Pharma (0 Trials) |
|
| remeglurant (MRZ-8456) / Merz Pharma (0 Trials) |
|
| Remescor (human umbilical cord derived mesenchymal stromal cells) / Primecell (0 Trials) |
|
| remetinostat (SHP-141) / Medivir, Biossil (0 Trials) |
|
| Remicade (infliximab) / J&J (200 Trials) |
|
| remifentanil / Generic mfg. (953 Trials) |
|
| remimazolam tosylate (HR-7056) / Jiangsu Hengrui Pharma (164 Trials) |
|
| Remitch (nalfurafine) / Toray, Mitsubishi Tanabe (3 Trials) |
|
| Remitch OD (nalfurafine hydrochloride orally disintegrating tablet) / Toray, Japan Tobacco, Sumitomo Pharma (0 Trials) |
|
| remlarsen (MRG-201) / Viridian Therap (0 Trials) |
|
| remlifanserin (ACP-204) / Acadia Pharma (0 Trials) |
|
| Remofuscin (soraprazan) / Katairo (0 Trials) |
|
| Remoxy ER (extended-release oxycodone capsules CII) / Filana Therapeutics (0 Trials) |
|
| Remozen (remogliflozin etabonate) / Islet Sci (1 Trials) |
|
| remternetug (LY3372993) / Eli Lilly (0 Trials) |
|
| remtolumab (ABT-122) / AbbVie (0 Trials) |
|
| Remune (gp 120-depleted HIV-1) / Immune Response BioPharma (1 Trials) |
|
| RemuneX (IR103) / Immune Response BioPharma (1 Trials) |
|
| REN-001 / Rocket Pharma (0 Trials) |
|
| renadirsen (DS-5141) / Daiichi Sankyo, Orphan Disease Treatment Institute (0 Trials) |
|
| Renaparin / Corline Biomedical (0 Trials) |
|
| Renazorb (lanthanum dioxycarbonate) / Unicycive (0 Trials) |
|
| RENB-DC-11 / Lunai Bioworks (0 Trials) |
|
| RENB-DC-12-XX / Lunai Bioworks (0 Trials) |
|
| RENB-HB-01 / Lunai Bioworks (0 Trials) |
|
| RENB-HV-01 / Lunai Bioworks (0 Trials) |
|
| RENB-HV-12 / Lunai Bioworks (0 Trials) |
|
| RENB-HV-21 / Lunai Bioworks (0 Trials) |
|
| Rencarex (girentuximab) / Heidelberg Pharma, Esteve, Merck (MSD) (5 Trials) |
|
| rencofilstat (CRV431) / Hepion Pharma (0 Trials) |
|
| Renexin CR (cilostazol/Ginkgo biloba leaf extract sustained release) / SK Bio (0 Trials) |
|
| Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Ewopharma, Samsung, Organon (9 Trials) |
|
| Renin/prorenin receptor blocker therapy / CCRP Therap (0 Trials) |
|
| renizgamglogene autogedtemcel (EDIT-301) / Editas Medicine (0 Trials) |
|
| Renogen (epoetin alfa biosimilar) / Unilab (0 Trials) |
|
| RenovoGem (gemcitabine with RenovoCath) / RenovoRx (0 Trials) |
|
| rentosertib (INS018_055) / Insilico Medicine (0 Trials) |
|
| renvistobart (BMS-986207) / BMS (1 Trials) |
|
| renzapride (AZM 112) / Atlantic Healthcare (0 Trials) |
|
| ReoCure (RC402) / ViroCure (0 Trials) |
|
| Reolysin (pelareorep) / Oncolytics (5 Trials) |
|
| reozalimab (IBI318) / Eli Lilly (0 Trials) |
|
| reozalimab (LY3434172) / Eli Lilly (0 Trials) |
|
| REP 2139 / Replicor (1 Trials) |
|
| REP 2165-Mg / Replicor (1 Trials) |
|
| repaglinide / Generic mfg. (13 Trials) |
|
| reparixin (DF 1681Y) / Dompe (1 Trials) |
|
| Repatha (evolocumab) / Amgen, Astellas (86 Trials) |
|
| repeat expansion disorders therapeutics / Triplet Therap (0 Trials) |
|
| repibresib (VYN201) / Yarrow Bioscience (0 Trials) |
|
| repinatrabit (JNT-517) / Otsuka (0 Trials) |
|
| Replagal (agalsidase alfa) / Samaritan Pharma, Takeda (6 Trials) |
|
| Replenine-VF (human plasma derived coagulation factor IX) / Bio Products Lab (0 Trials) |
|
| Replicating defective SARS-CoV-2 derived RNAs based vaccine / National Biotechnology Center (0 Trials) |
|
| Replicating measles vector based vaccine / State Research Center of Virology and Biotechnology Vector (0 Trials) |
|
| Replicating VSV vector based vaccine / State Research Center of Virology and Biotechnology Vector (0 Trials) |
|
| Repoitin (recombinant human erythropoietin biosimilar) / Serum Institute of India (0 Trials) |
|
| Repomax (recombinant human erythropoietin biosimilar) / Fresenius Kabi (0 Trials) |
|
| repositioned drugs / IHU Mediterranean Infection, Pharnext (0 Trials) |
|
| Repotin (recombinant human erythropoietin biosimilar) / Genius Biotherapeutics (1 Trials) |
|
| Repretin (epoetin alfa biosimilar) / SEDICO, Rotapharm (0 Trials) |
|
| reproxalap ophthalmic (ADX-102 ophthalmic) / Aldeyra (0 Trials) |
|
| reproxalap systemic (ADX-102 systemic) / Aldeyra (0 Trials) |
|
| reproxalap topical (ADX-102 topical) / Aldeyra (0 Trials) |
|
| Reqorsa (quaratusugene ozeplasmid) / Genprex (2 Trials) |
|
| ReS12-S / ReMYND (0 Trials) |
|
| ReS18-H / ReMYND (0 Trials) |
|
| ReS19-T / ReMYND (0 Trials) |
|
| ReS3-T / ReMYND (0 Trials) |
|
| ReS39 / Novo Nordisk, ReMYND (0 Trials) |
|
| ReS9-S / ReMYND (0 Trials) |
|
| ReS9-S7 / ReMYND (0 Trials) |
|
| resamirigene bilparvovec (AT132) / Astellas (0 Trials) |
|
| resatorvid (TAK-242) / Takeda, Akaza Bioscience (0 Trials) |
|
| Rescriptor (delavirdine mesylate) / ViiV Healthcare (0 Trials) |
|
| Rescue-G (glucagon RTU nanoemulsion) / LATITUDE Pharma (0 Trials) |
|
| Rescula (unoprostone isopropyl) / Santen, Mallinckrodt (0 Trials) |
|
| ResCure / ProgenaBiome (0 Trials) |
|
| resecabtagene autoleucel (CABA-201) / Cabaletta Bio (0 Trials) |
|
| resencatinib (HS-10365) / Jiangsu Hansoh Pharma (0 Trials) |
|
| Resimmune (VG712) / Virogen Biotech (1 Trials) |
|
| resiniferatoxin (GRT7039) / Grunenthal (0 Trials) |
|
| resiniferatoxin (MCP-101) / Sorrento (2 Trials) |
|
| resiquimod (STM-416) / SURGE Therap (0 Trials) |
|
| resiquimod pegol (NKTR-262) / Nektar Therapeutics (0 Trials) |
|
| resiquimod SR (TransCon TLR7/8 Agonist) / Ascendis (0 Trials) |
|
| resiquimod sulfate (EIK1001) / Eikon Therap (0 Trials) |
|
| Resolaris (resokine) / aTyr Pharma (0 Trials) |
|
| Resolute ZES (zotarolimus-eluting stent) / Medtronic (0 Trials) |
|
| resolvin E1 (RX-10001) / Resolvyx (0 Trials) |
|
| resolvin E1 (TP-317) / Thetis Pharma (0 Trials) |
|
| resomelagon (AP1189) / SynAct Pharma (7 Trials) |
|
| RESP-X / Infex Therap (0 Trials) |
|
| RESP1000 / Respiratorius, Cadila (0 Trials) |
|
| RESP2000 / Respiratorius (0 Trials) |
|
| Respectrum (cannabidiol/palmitoylethanolamide) / SciSparc (0 Trials) |
|
| respiratory disorder therapeutics / Vicenna Pharma (0 Trials) |
|
| respiratory syncytial virus (RSV) vaccine (GSK3389245A) / GSK (0 Trials) |
|
| RespRx (cannabidiol) / PAO Group (0 Trials) |
|
| Restasis MDPF (multi-dose preservative free ciclosporin ophthalmic formulation) / AbbVie (0 Trials) |
|
| Restasis X (ciclosporin ophthalmic new formulation) / AbbVie (0 Trials) |
|
| restem-L / Restem (0 Trials) |
|
| Restylane / Bausch Health (9 Trials) |
|
| Restylane-L / Bausch Health (1 Trials) |
|
| Resunab (lenabasum) / Corbus Pharma, Kaken Pharma (1 Trials) |
|
| ReSure / Ocular Therap (1 Trials) |
|
| ResVax (respiratory syncytial virus F-protein nanoparticle vaccine) / Novavax (0 Trials) |
|
| resveratrol (DB02709) / Alzheimer's Disease Cooperative Study (0 Trials) |
|
| resveratrol (GSK184072) / GSK (0 Trials) |
|
| resveratrol (RM 1812) / Royalmount Pharma (0 Trials) |
|
| RET specific inhibitor / Tyra Biosci (0 Trials) |
|
| Retacrit (epoetin alfa-epbx) / Stada, Norbitec, Pfizer (3 Trials) |
|
| retaspimycin (IPI-504) / Infinity Pharma (0 Trials) |
|
| retatrutide (LY3437943) / Eli Lilly (0 Trials) |
|
| Retavase (reteplase) / Chiesi (0 Trials) |
|
| Retevmo (selpercatinib) / Eli Lilly (24 Trials) |
|
| Rethymic (allogeneic processed thymus tissue-agdc) / Sumitomo Pharma (0 Trials) |
|
| reticulose (EOM613) / EOM Pharma (1 Trials) |
|
| Retinitis Pigmentosa therapy / Wave Life Sciences (0 Trials) |
|
| Retinitis Pigmentosa therapy / Staidson Biopharma (0 Trials) |
|
| Retinostat (OXB-201) / Oxford Biomedica (1 Trials) |
|
| Retisert (fluocinolone acetonide intravitreal implant) / Bausch Health, EyePoint Pharma (2 Trials) |
|
| retosiban (GSK-221,149-A) / GSK (0 Trials) |
|
| RETRA / Cleveland Clinic Lerner College of Medicine (0 Trials) |
|
| Retuxira (rituximab biosimilar) / 3SBio (0 Trials) |
|
| Reumacon A (CPH-82) / Viatris (0 Trials) |
|
| Revacept (soluble dimeric glycoprotein VI-Fc fusion protein) / advanceCOR (0 Trials) |
|
| Revamilast (GRC-4039) / Glenmark (0 Trials) |
|
| Revanex (revaprazan) / Yuhan Corp (0 Trials) |
|
| Revascor (rexlemestrocel-L) / Mesoblast, Grunenthal (2 Trials) |
|
| RevCAR-T1 / AvenCell Therap (0 Trials) |
|
| Revcovi (elapegademase-lvlr) / Teijin, Chiesi (1 Trials) |
|
| revdofilimab (ABBV-368) / AbbVie (1 Trials) |
|
| reveglucosidase alfa (BMN 701) / BioMarin (0 Trials) |
|
| Rever3mab / Takis (0 Trials) |
|
| Revercom (liposomal reversan) / Statera BioPharma (0 Trials) |
|
| ReViVox (pyridostigmine) / DelNova (0 Trials) |
|
| Revolixys (anivamersen/pegnivacogin) / AbbVie (1 Trials) |
|
| revottack / Huawe Medicine, Affiliated Hospital of Xuzhou Medical University (0 Trials) |
|
| Revtorpyk (gedatolisib) / Celcuity (9 Trials) |
|
| Revuforj (revumenib) / Syndax Pharma (0 Trials) |
|
| revusiran (ALN-TTRsc) / Alnylam, Sanofi (1 Trials) |
|
| rexaceract (GT-02287) / Gain Therap (0 Trials) |
|
| rExenatide-4 / CSPC Pharma (0 Trials) |
|
| rexlemestrocel intradiscal (MPC-06-ID) / Mesoblast, Grunenthal (0 Trials) |
|
| Rexomun (ertumaxomab) / Trion Pharma (0 Trials) |
|
| Reyobiq (rhenium Re186 obisbemeda) / Cerenome (0 Trials) |
|
| Reyvow (lasmiditan) / Eli Lilly (1 Trials) |
|
| rezafungin topical (CD101 topical) / Merck (MSD) (0 Trials) |
|
| rezanecel (NRTX-1001) / UCB (0 Trials) |
|
|